Skip to main content

previous disabled Page of 9
and
  1. Article

    Open Access

    A Cullin 5-based complex serves as an essential modulator of ORF9b stability in SARS-CoV-2 replication

    The ORF9b protein, derived from the nucleocapsid’s open-reading frame in both SARS-CoV and SARS-CoV-2, serves as an accessory protein crucial for viral immune evasion by inhibiting the innate immune response. ...

    Yuzheng Zhou, Zongpeng Chen, Sijie Liu in Signal Transduction and Targeted Therapy (2024)

  2. Article

    Open Access

    DNA of neutrophil extracellular traps promote NF-κB-dependent autoimmunity via cGAS/TLR9 in chronic obstructive pulmonary disease

    Chronic obstructive pulmonary disease (COPD) is characterised by persistent airway inflammation even after cigarette smoking cessation. Neutrophil extracellular traps (NETs) have been implicated in COPD severi...

    Jun Chen, Tao Wang, **aoou Li, Lijuan Gao in Signal Transduction and Targeted Therapy (2024)

  3. Article

    Open Access

    Initial COVID-19 severity influenced by SARS-CoV-2-specific T cells imprints T-cell memory and inversely affects reinfection

    The immunoprotective components control COVID-19 disease severity, as well as long-term adaptive immunity maintenance and subsequent reinfection risk discrepancies across initial COVID-19 severity, remain uncl...

    Gang Yang, **peng Cao, Jian Qin, **nyue Mei in Signal Transduction and Targeted Therapy (2024)

  4. Article

    Open Access

    DEAD-box helicase 17 (DDX17) protects cardiac function by promoting mitochondrial homeostasis in heart failure

    DEAD-box helicase 17 (DDX17) is a typical member of the DEAD-box family with transcriptional cofactor activity. Although DDX17 is abundantly expressed in the myocardium, its role in heart is not fully understo...

    Ming**g Yan, Junpeng Gao, Ming Lan, Que Wang in Signal Transduction and Targeted Therapy (2024)

  5. Article

    Open Access

    Multiomics integration reveals NETosis heterogeneity and TLR2 as a prognostic biomarker in pancreatic cancer

    Pancreatic ductal adenocarcinoma (PDAC) is a highly malignant neoplasm characterized by a poor prognosis and limited therapeutic strategy. The PDAC tumor microenvironment presents a complex heterogeneity, wher...

    Yifan Fu, **xin Tao, Yani Gu, Yueze Liu, Jiangdong Qiu, Dan Su in npj Precision Oncology (2024)

  6. Article

    Open Access

    Tumor biomarkers for diagnosis, prognosis and targeted therapy

    Tumor biomarkers, the substances which are produced by tumors or the body’s responses to tumors during tumorigenesis and progression, have been demonstrated to possess critical and encouraging value in screeni...

    Yue Zhou, Lei Tao, Jiahao Qiu, **g Xu in Signal Transduction and Targeted Therapy (2024)

  7. No Access

    Article

    Ferritin-mediated mitochondrial iron homeostasis is essential for the survival of hematopoietic stem cells and leukemic stem cells

    Iron metabolism plays a crucial role in cell viability, but its relationship with adult stem cells and cancer stem cells is not fully understood. The ferritin complex, responsible for intracellular iron storag...

    Weiwei Yi, **hua Zhang, Yingxin Huang, Qiang Zhan, Mi Zou, **ang Cheng in Leukemia (2024)

  8. Article

    Open Access

    A positive feedback inhibition of isocitrate dehydrogenase 3β on paired-box gene 6 promotes Alzheimer-like pathology

    Impaired brain glucose metabolism is an early indicator of Alzheimer’s disease (AD); however, the fundamental mechanism is unknown. In this study, we found a substantial decline in isocitrate dehydrogenase 3β ...

    **n Wang, Qian Liu, Hai-tao Yu, Jia-zhao **e in Signal Transduction and Targeted Therapy (2024)

  9. Article

    Open Access

    FGF7 enhances the expression of ACE2 in human islet organoids aggravating SARS-CoV-2 infection

    The angiotensin-converting enzyme 2 (ACE2) is a primary cell surface viral binding receptor for SARS-CoV-2, so finding new regulatory molecules to modulate ACE2 expression levels is a promising strategy agains...

    Hao Meng, Zhiying Liao, Yanting Ji, Dong Wang in Signal Transduction and Targeted Therapy (2024)

  10. Article

    Open Access

    Phase II study of novel orally PI3Kα/δ inhibitor TQ-B3525 in relapsed and/or refractory follicular lymphoma

    This registration study assessed clinical outcomes of TQ-B3525, the dual phosphatidylinositol-3-kinase (PI3K) α/δ inhibitor, in relapsed and/or refractory follicular lymphoma (R/R FL). This phase II study (Cli...

    Huaqing Wang, Jifeng Feng, Yanyan Liu in Signal Transduction and Targeted Therapy (2024)

  11. Article

    Open Access

    Mex-3 RNA binding family member A (MEX3A)/circMPP6 complex promotes colorectal cancer progression by inhibiting autophagy

    RNA-binding proteins (RBPs)-RNA networks have contributed to cancer development. Circular RNAs (circRNAs) are considered as protein recruiters; nevertheless, the patterns of circRNA-protein interactions in col...

    Ri-**n Chen, Shui-Dan Xu, Min-Hua Deng in Signal Transduction and Targeted Therapy (2024)

  12. No Access

    Article

    Genomic features reveal potential benefit of adding anti-PD-1 immunotherapy to treat non-upper aerodigestive tract natural killer/T-cell lymphoma

    Natural killer/T-cell lymphoma (NKTCL) is a highly heterogeneous disease with a poor prognosis. However, the genomic characteristics and proper treatment strategies for non-upper aerodigestive tract NKTCL (NUA...

    Zegeng Chen, He Huang, Huageng Huang, Le Yu, Huawei Weng, Jian **ao, Liqun Zou in Leukemia (2024)

  13. Article

    Open Access

    TGF-β signaling in health, disease, and therapeutics

    Transforming growth factor (TGF)-β is a multifunctional cytokine expressed by almost every tissue and cell type. The signal transduction of TGF-β can stimulate diverse cellular responses and is particularly cr...

    Ziqin Deng, Tao Fan, Chu **ao, He Tian in Signal Transduction and Targeted Therapy (2024)

  14. Article

    Open Access

    Adaptive Darwinian off-target resistance mechanisms to selective RET inhibition in RET driven cancer

    Patients treated with RET protein tyrosine kinase inhibitors (TKIs) selpercatinib or pralsetinib develop RET TKI resistance by secondary RET mutations or alterative oncogenes, of which alterative oncogenes pos...

    Vivek Subbiah, Mohamed A. Gouda, J. Bryan Iorgulescu, Ramona Dadu in npj Precision Oncology (2024)

  15. Article

    Open Access

    Tertiary lymphoid structures predict survival and response to neoadjuvant therapy in locally advanced rectal cancer

    Tertiary lymphoid structure (TLS) contributes to the anti-tumor immune response, and predicts the prognosis of colorectal cancer patients. However, the potential impact of TLS in sha** the immune status of r...

    Qianyu Wang, Wentao Zhong, **aofei Shen, Zechen Hao, Meng Wan in npj Precision Oncology (2024)

  16. Article

    Open Access

    Alternative splicing and related RNA binding proteins in human health and disease

    Alternative splicing (AS) serves as a pivotal mechanism in transcriptional regulation, engendering transcript diversity, and modifications in protein structure and functionality. Across varying tissues, develo...

    Yining Tao, Qi Zhang, Haoyu Wang, **yu Yang in Signal Transduction and Targeted Therapy (2024)

  17. Article

    Open Access

    A protein-encoding CCDC7 circular RNA inhibits the progression of prostate cancer by up-regulating FLRT3

    Circular RNAs (circRNAs) are a family of endogenous RNAs that have become a focus of biological research in recent years. Emerging evidence has revealed that circRNAs exert biological functions by acting as tr...

    Qiong Wang, Bisheng Cheng, Sandeep Singh, Yiran Tao, Zhongqiu **e in npj Precision Oncology (2024)

  18. Article

    Open Access

    Vertical pathway inhibition of receptor tyrosine kinases and BAD with synergistic efficacy in triple negative breast cancer

    Aberrant activation of the PI3K/AKT signaling axis along with the sustained phosphorylation of downstream BAD is associated with a poor outcome of TNBC. Herein, the phosphorylated to non-phosphorylated ratio o...

    Yan Qin Tan, Yi-Shiou Chiou, Hui Guo, Shuwei Zhang in npj Precision Oncology (2024)

  19. Article

    Open Access

    Josephin domain containing 2 (JOSD2) promotes lung cancer by inhibiting LKB1 (Liver kinase B1) activity

    Non-small cell lung cancer (NSCLC) ranks as one of the leading causes of cancer-related deaths worldwide. Despite the prominence and effectiveness of kinase-target therapies in NSCLC treatment, these drugs are...

    Tao Yuan, Chenming Zeng, Jiawei Liu in Signal Transduction and Targeted Therapy (2024)

  20. Article

    Open Access

    Trogocytosis of CAR molecule regulates CAR-T cell dysfunction and tumor antigen escape

    Chimeric antigen receptor (CAR) T-cell therapy has demonstrated clinical response in treating both hematologic malignancies and solid tumors. Although instances of rapid tumor remissions have been observed in ...

    You Zhai, Yicong Du, Guanzhang Li, Mingchen Yu in Signal Transduction and Targeted Therapy (2023)

previous disabled Page of 9